Clinics in Dermatology
Volume 26, Issue 3 , Pages 296-305 , May 2008

Hair, nail, and pigment changes in major systemic disease

References 

  1. Fawcet RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic diseases. Am Fam Physician. 2004;69:1417–1424
  2. Zaiac MN, Daniel CR. Nails in systemic disease. Dermatol Ther. 2002;15:99–106
  3. Spicknall KE, Zirwas MJ, English JC. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005;52:1020–1028
  4. Myers KA, Farquar DRE. Does this patient have clubbing?. JAMA. 2001;286:341–347
  5. Al-Dabbagh TQ, Al-Abachi KG. Nutritional koilonychias in 32 Iraqi subjects. Ann Saudi Med. 2005;25:154–157
  6. Hwang SM, Lee SH, Ahn SK. Pincer nail deformity and pseudo-Kaposi's sarcoma: complications of an artificial arteriovenous fistula for haemodialysis. Br J Dermatol. 1999;141:1129–1132
  7. Majeski C, Ritchie B, Giuffre M, Lauzon G. Pincer nail deformity associated with systemic lupus erythematosus. J Cutan Med Surg. 2005;9:2–5
  8. Vanderhooft SL, Vanderhooft JE. Pincer nail deformity after Kawasaki's disease. J Am Acad Dermatol. 1999;41:341–342
  9. Rich P. Nail changes due to diabetes and other endocrinopathies. Dermatol Ther. 2002;15:107–110
  10. Little BJ, Cowan MA. Lichen planus–like eruptions and nail changes in a patient with graft-versus-host disease. Br J Dermatol. 1990;122:841–843
  11. Patki AH, Metha JM. Pterygium unguis in a patient with recurrent type 2 lepra reaction. Cutis. 1989;44:311–312
  12. Vadmal M, Reyter I, Oshtory S, Hensley B, Woodley DT. Pterygium inversum unguis associated with stroke. J Am Acad Dermatol. 2005;53:501–503
  13. Tosti A, Piraccini BM. Treatment of common nail disorders. Dermatol Clin. 2000;18:339–348
  14. Khandpur S, Reddy BS. An association of twenty-nail dystrophy with vitiligo. J Dermatol. 2001;28:38–42
  15. Cutolo M, Cimmino MA, Accardo S. Nail involvement in osteoarthritis. Clin Rheumatol. 1990;9:242–245
  16. de Berker DA, Perrin C, Baran R. Localized longitudinal erythronychia: diagnostic significance and physical explanation. Arch Dermatol. 2004;140:1253–1257
  17. Baran R, Perrin C. Longitudinal erythronychia with distal subungual keratosis: onychopapilloma of the nail bed and Bowen's disease. Br J Dermatol. 2000;143:132–135
  18. Gee BC, Millard PR, Dawber RP. Onychopapilloma is not a distinct clinico-pathological entity. Br J Dermatol. 2002;146:156–157
  19. Silva PP, Vera KC, Kolbach RM, Fernandez LF. Suspicion of systemic diseases through nails abnormalities. Rev Med Chil. 2006;134:231–238
  20. Cribier B, Mena ML, Rey D, et al. Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol. 1998;134:1216–1220
  21. Chao SC, Lee JY. Brittle nails and dyspareunia as first clues to recurrences of malignant glucagonoma. Br J Dermatol. 2002;146:1071–1074
  22. Van de Kerkhof PCM, Pasch MC, Scher RK, Kerscher M, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53:644–651
  23. Alam M, Scher RK, Bikers DR. Muehrcke's lines in a heart transplant recipient. J Am Acad Dermatol. 2001;44:316–317
  24. Robinson-Bostom L, DiGiovanna JJ. Cutaneous manifestations of end-stage renal disease. J Am Acad Dermatol. 2000;43:975–986
  25. Zagoni T, Sipos F, Tarjan Z, Peter Z. The half-and-half nail: a new sign of Crohn's disease? Report of four cases. Dis Colon Rectum. 2006;49:1071–1073
  26. Holzberg M, Walker HK. Terry's nail: revised definition and new correlations. Lancet. 1984;2:896
  27. Riedel M. Multiple effusions and lymphedema in the yellow nail syndrome. Circulation. 2002;105:E25–E26
  28. D'Alessandro A, Muzi G, Monaco A, Filiberto S, Barboni A, Abbritti G. Yellow nail syndrome: does protein leakage play a role?. Eur Respir J. 2001;17:149–152
  29. Cohen PR. The lunula. J Am Acad Dermatol. 1996;34:943–953
  30. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27:389–395
  31. Sperling LC. Hair and systemic disease. Dermatol Clin. 2001;19:711–726
  32. Chartier MB, Hoss DM, Grant-Kels JM. Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol. 2002;47:809–818
  33. Dawber R, Simpson N. Hair and scalp in systemic diseases. In:  Dawber R editors. Diseases of the hair and scalp. 3rd ed. Oxford: Blackwell Science; 1997;p. 483–488
  34. Hordinsky M. Alopecia areata: pathophysiology and latest developments. J Cutan Med Surg. 1999;3:S28–S30
  35. Vowels M, Chan LL, Giri N, Russell S, Lam-Po-Tang R. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant. 1993;12:347–350
  36. Miwa LJ, Shaefer MS, Stratta RJ, Wood RP, Langnas AM, Shaw BW. Drug-induced hypertrichosis: case report and review of the literature. DICP. 1990;24:365–368[Comment in: DICP. 1990;24(11):1124]
  37. Braverman IM. Cancer. In:  Braverman IM editors. Skin signs of systemic disease. 3rd ed. Philadelphia: WB Saunders; 1998;p. 1–71
  38. Braverman IM. Endocrine and metabolic diseases. In:  Braverman IM editors. Skin signs of systemic disease. 3rd ed. Philadelphia: WB Saunders; 1998;p. 439–491
  39. Hordinsky M, Sawaya M, Roberts JL. Hair loss and hirsutism in the elderly. Clin Geriatr Med. 2002;18:121–133
  40. Ramos-e-Silva M, Jacques CM, Carneiro SCS. Hair and nail in the elderly. In:  Norman R editors. Differential diagnosis of aging skin diseases. London: Springer-Verlag; 2008;[in press]
  41. Hearing VJ. Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci. 2005;37:3–14
  42. Bennett DC, Lamoreux ML. The color loci of mice—a genetic century. Pigment Cell Res. 2003;16:333–344
  43. Tobin DJ, Kauser S. Hair melanocytes as neuro-endocrine sensors—pigments for our imagination. Mol Cell Endocrinol. 2005;243:1–11
  44. Peters A. The self-similarity of the melanocortin system. Endocrinology. 2005;16:529–531
  45. Maeda M, Kachi H, Katsutoshi M, Shunji M, Kitajima Y. Pigmentation abnormalities in systemic scleroderma examined by using a colorimeter (Choromo Meter CR-200). J Dermatol Sci. 1996;11:228–233
  46. Ramos-e-Silva M, Carneiro SCS. Elderly skin and its rejuvenation. Products and procedures for the aging skin. J Cosm Dermatol. 2007;6:40–50
  47. Stulberg DL, Clark N, Tovey D. Common hyperpigmentation disorders in adults: part I. Diagnostic approach, cafe au lait macules, diffuse hyperpigmentation, sun exposure, and phototoxic reactions. Am Fam Physician. 2003;68:1955–1960
  48. Braverman IM. Connective tissue (rheumatic) diseases. In:  Braverman IM editors. Skin signs of systemic disease. 3rd ed. Philadelphia: WB Saunders; 1998;p. 198–277
  49. Scheinfeld NS, DiCostanzo D, Cohen SR. Reticulate and stellate acral pigmentation associated with systemic lupus erythematosus and high titers of circulating anticardiolipin antibodies: a possible association with acral microlivedo. J Drugs Dermatol. 2003;2:674–676
  50. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20:387–408
  51. Giuffrida TJ, Kerdel FA. Sarcoidosis. Dermatol Clin. 2002;20:435–447
  52. Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin. 2002;20:473–481
  53. Stulberg DL, Clark N, Tovey D. Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor and postinflammatory hyperpigmentation. Am Fam Physician. 2003;68:1963–1968
  54. Feringer T, Miller F. Cutaneous manifestations of diabetes mellitus. Dermatol Clin. 2002;20:483–492
  55. Jackson EM, English JC. Diffuse cutaneous mucinoses. Dermatol Clin. 2002;20:493–501
  56. Grimes P, Nordlund JJ, Pandya AG, Taylor S, Rendon M, Ortonne JP. Increasing our understanding of pigmentary disorders. J Am Acad Dermatol. 2006;54:S255–S261
  57. Jackson JM. Hepatitis C and the skin. Dermatol Clin. 2002;20:449–458
  58. Fisher AA, Davi MW. Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture. A case report and literature review. Clin Med Res. 2004;4:209–215
  59. Braverman IM. Skin manifestations of internal malignancy. Clin Geriatr Med. 2002;18:1–19
  60. Boyce S, Harper J. Paraneoplastic dermatoses. Dermatol Clin. 2002;20:523–532
  61. Barbagallo JS, Kolodzieh MS, Silverberg NB, Weinberg JM. Neurocutaneous disorders. Dermatol Clin. 2002;20:547–550

PII: S0738-081X(07)00242-8

doi: 10.1016/j.clindermatol.2007.10.019

Clinics in Dermatology
Volume 26, Issue 3 , Pages 296-305 , May 2008

Article Tools

* Image Usage & Resolution